Matthew Ingham
7PUBLICATIONS
71CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 24, 2025
Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor.Prabhjot S Mundi, Adina Grunn, Arsenije Kojadinovic
|Jun 11, 2025
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.Kevin J Harrington, Stephane Champiat, Joshua D Brody
|Jul 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint Blockade.Karan Luthria, Parin Shah, Blake Caldwell
|Apr 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.Brian A Van Tine, Matthew A Ingham, Steven Attia
|Jul 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).Matthew Ingham, Jacob B Allred, Li Chen
|Dec 22, 2022
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma.Matthew Ingham, Shing Lee, Brian A Van Tine
Pageof 2
Frequent Collaborators
5 joint publications
Gary K Schwartz
3 joint publications
Sminu Bose
2 joint publications
Brian A Van Tine
2 joint publications
Steven Attia
2 joint publications
Gregory M Cote
1 joint publications
Christian F Meyer
1 joint publications
Esther Brooks-Asplund
1 joint publications
Tristan Lee
1 joint publications
Michael J Rasiej
1 joint publications
Shing Lee
